Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.220
-0.040 (-1.77%)
At close: Sep 11, 2026, 4:00 PM EDT
2.230
+0.010 (0.45%)
Pre-market: Sep 14, 2026, 7:00 AM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $46.7 million as of September 11, 2026. Its market cap has increased by 3.55% in one year.
Market Cap
46.70M
Enterprise Value
32.94M
1-Year Change
3.55%
Ranking
Category
Stock Price
$2.22
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $46.70M, a decrease of -99.31%. That is a compound annual growth rate of -34.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 46.70M | -4.50% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 50.96M |
| Instil Bio | 50.05M |
| Seres Therapeutics | 49.81M |
| Impact BioMedical | 49.62M |
| Tevogen | 47.92M |
| Werewolf Therapeutics | 47.72M |
| Annovis Bio | 47.72M |
| Mereo BioPharma Group | 44.71M |